Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer [Neoadjuvante, adjuvante und palliative Chemotherapie des Peniskarzinoms]

被引:0
|
作者
Protzel C. [1 ]
Seitz A.K. [2 ]
Hakenberg O.W. [1 ]
Retz M. [2 ]
机构
[1] Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, E. Heydemannstraße 6
[2] Klinikum Rechts der Isar, Technischen Universität München, München
来源
Der Urologe | 2013年 / 52卷 / 11期
关键词
Best supportive care strategie; Lymph node metastases; Multimodal therapy concept; Salvage lympadenectomy; Targeted therapy;
D O I
10.1007/s00120-013-3252-z
中图分类号
学科分类号
摘要
Data on the treatment of advanced penile carcinoma especially for chemotherapy are very limited. Due to the results of recent studies there has been a shift to taxan/cisplatinum based regimens. Initial case reports also showed a response to targeted therapy especially antibodies against epidermal growth factor receptor (EGFR). Nevertheless, a curative treatment by medicinal approaches alone does not appear to be possible for metastatic penile cancer and can be only cured by multimodal approaches, including neoadjuvant and adjuvant chemotherapy and salvage lymph node dissection. Palliative chemotherapy of advanced penile cancer has to be individually adapted and weighed against best supportive care for the final decision. © 2013 Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:1556 / 1563
页数:7
相关论文
共 50 条
  • [41] Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials
    Lamberti, C
    Lundin, S
    Bogdanow, M
    Gorschlüter, M
    Schmidt-Wolf, IGH
    Sauerbruch, T
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (10) : 485 - 490
  • [42] QUALITY OF LIFE IN LUNG CANCER PATIENTS DURING ADJUVANT OR PALLIATIVE CHEMOTHERAPY
    Wintner, L. M.
    Zabernigg, A.
    Giesinger, J. M.
    Sztankay, M.
    Gattringer, K.
    Gamper, E. M.
    Holzner, B.
    VALUE IN HEALTH, 2012, 15 (07) : A430 - A430
  • [43] Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older
    Popescu, RA
    Norman, A
    Ross, PJ
    Parikh, B
    Cunningham, D
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2412 - 2418
  • [44] Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy
    Aznab M.
    Beiki O.
    pia K.E.
    Setayeshi K.
    Hesami M.A.
    Vrae H.
    Journal of Gastrointestinal Cancer, 2017, 48 (1) : 31 - 37
  • [45] Results and toxicity of adjuvant and palliative chemotherapy for colorectal cancer (CRC) in elderly patients
    Popescu, RA
    Norman, A
    Ross, PJ
    Cunningham, D
    BRITISH JOURNAL OF CANCER, 1998, 78 : 29 - 29
  • [46] Neoadjuvante Chemotherapie beim operablen Kolonkarzinom – ein potenzieller neuer Standard?Neoadjuvant chemotherapy in operable colon cancer: is this a potential new standard?
    Georg W. Wurschi
    Strahlentherapie und Onkologie, 2024, 200 (1) : 97 - 98
  • [47] Breast Cancer Patients Receiving Neoadjuvant, Adjuvant and Palliative Chemotherapy Have Different DNA Oxidative Damage and Repair Profiles.
    Laura, V-R
    MCarmen, R-T
    Pedro, S-R
    Cesar, R-T L.
    Sergio, G-P
    Jose, L. A.
    Jose, Q. L.
    CANCER RESEARCH, 2009, 69 (24) : 578S - 578S
  • [48] PALLIATIVE CHEMOTHERAPY WITH CMF AFTER THE SAME ADJUVANT REGIMEN FOR BREAST-CANCER
    GERRITSEN, M
    WAGENER, DJT
    SCHADE, RWB
    BEEX, LVAM
    NETHERLANDS JOURNAL OF MEDICINE, 1995, 46 (03): : 131 - 135
  • [49] Importance of intensified chemotherapy and of new drugs for the adjuvant and palliative treatment of colorectal cancer
    Köhne, CH
    CHIRURGISCHE GASTROENTEROLOGIE, 2005, 21 (02): : 145 - 150
  • [50] Testicular cancer - Is there an indication for adjuvant or neoadjuvant systemic therapy? [Hodenkarzinom - Gibt es eine indikation für eine adjuvante oder neoadjuvante systemtherapie?]
    Langenkamp S.
    Albers P.
    Der Urologe, 2007, 46 (10): : 1389 - 1394